It is time for the government to move away from the outdated practice of lowest bidding (L1) in public procurement and adopt the globally accepted Quality-cum-Cost-Based Selection (QCBS) method. This ...

Gastric synovial sarcoma (GSS) is an exceptionally rare mesenchymal malignancy, with only 51 cases reported. We present a ...

The patients with intrahepatic cholangiocarcinoma (iCCA) are highly susceptible to recurrence after radical resection, while predicting recurrence remains challenging. Adjacent-to-tumor tissues (ATTs) ...

ABSTRACT: Darcy’s law is the fundamental equation describing the flow of a fluid through a porous medium. Combined with the principle of mass conservation, it leads to the diffusion Equation (e.g., ...

aDepartment of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center & St Antonius Hospital Nieuwegein, Utrecht University, Utrecht, Netherlands bDepartment of Medical Oncology, ...

Naturalistic interactions involve dynamic, nonlinear coordination that unfolds across multiple timescales, yet most hyperscanning studies rely on analytical methods designed for passive, ...

Added linear search algorithm's code on 15th February, 2026. Added binary search algorithm's code on 15th February, 2026. Added binary search (left most index) algorithm's code on 17th February, 2026.

Google launched four official and confirmed algorithmic updates in 2025, three core updates and one spam update. This is in comparison to last year, in 2024, where we had seven confirmed updates, then ...

In patients with cryptogenic stroke, the characteristics of multiterritory brain infarcts, the recurrent stroke risk, and the response to anticoagulation remain unclear. Among 3464 patients with ...

Background/objectives Rilonacept (RI), an interleukin (IL)-1α/β cytokine trap, is a biological treatment to prevent recurrence in recurrent pericarditis (RP). Discontinuation of RI in patients after ...

Association between prostate specific membrane antigen imaging and initial treatment for prostate cancer among commercial insurance beneficiaries. This is an ASCO Meeting Abstract from the 2025 ASCO ...